Skip to main content
. 2021 Sep 30;59(1):1332–1348. doi: 10.1080/13880209.2021.1979051

Table 11.

Pharmacokinetic parameters of 8 compounds after oral administration of TWMM (n = 6).

Compounds Tmax
(h)
Cmax
(ng/mL)
t1/2
(h)
AUC (0–36)
(h·ng/mL)
AUC (0–∞)
(h·ng/mL)
MRT (0–36)
(h)
MRT (0–∞)
(h)
Oleuropein 1.37 ± 1.60 0.90 ± 0.82 3.36 ± 0.00 1.03 ± 0.75 1.03 ± 0.75 1.53 ± 1.25 1.54 ± 1.25
Chlorogenic acid 0.39 ± 0.32 16.13 ± 4.17 2.71 ± 0.11 33.95 ± 4.55 33.95 ± 4.55 4.97 ± 0.71 4.97 ± 0.71
Formononetin 0.46 ± 0.29 6.17 ± 1.65 11.70 ± 2.09 40.78 ± 8.51 45.96 ± 7.89 10.69 ± 1.17 15.73 ± 1.90
Verbascoside 0.25 ± 0.14 45.47 ± 21.16 2.08 ± 0.38 174.81 ± 40.83 174.81 ± 40.83 8.90 ± 3.44 8.91 ± 3.44
Linarin 0.16 ± 0.10 12.78 ± 8.82 2.81 ± 0.21 12.04 ± 4.72 12.04 ± 4.72 4.26 ± 2.67 4.26 ± 2.68
Luteolin 1.71 ± 1.79 3.27 ± 0.78 11.14 ± 10.20 38.46 ± 7.61 43.98 ± 4.19 11.36 ± 1.23 18.20 ± 9.14
Jaspolyside 0.38 ± 0.31 14.25 ± 3.67 29.15 ± 12.65 46.59 ± 9.58 53.37 ± 32.17 11.42 ± 1.29 15.62 ± 10.83
Specnuezhenide 0.46 ± 0.29 13.33 ± 4.61 20.27 ± 25.00 48.62 ± 19.41 57.19 ± 30.25 11.02 ± 5.63 19.29 ± 16.60